Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines through an extensive global network that spans more than 110 different countries. Celltrion Healthcare provides REMSIMA, the world's first biosimilar monoclonal antibody (mAb) approved by the European Medicines Agency (EMA) for the treatment of autoimmune disease, and innovative biopharmaceutical medications to help increase patient access to advanced therapies around the world. For additional information on our guidelines, please visit: https://bit.ly/3QyOyt7
We're tracking Celltrion Healthcare Co.,Ltd.'s market expansion
1 signal in the last 90 days.
How Celltrion Healthcare Co.,Ltd.'s international expansion compares to its competitors
Celltrion Healthcare Co.,Ltd.YouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 Celltrion Healthcare Co.,Ltd.You | 0 | 0 | — | 0 | 0 |
Sr. Associate - Procurement
View postingBranchburg, NJ · last wk.
Supply Chain Analyst
View postingBranchburg, NJ · last mo.
IT Compliance Analyst
View postingBranchburg, NJ · 5d ago
No active campaigns
Sign up to track this company and get alerted the moment something changes.
No recent news
Sign up to track this company and get alerted the moment something changes.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Celltrion Healthcare Co.,Ltd.'s business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
